Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT.
暂无分享,去创建一个
P. Acton | H. Kung | K. Plössl | H F Kung | P D Acton | S R Choi | C Hou | K Plössl | S. Choi | C. Hou
[1] S. Kushner,et al. Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography , 1999, European Journal of Nuclear Medicine.
[2] L. Farde,et al. Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] P. Acton,et al. Simplified quantification of dopamine transporters in humans using [99mTc]TRODAT-1 and single-photon emission tomography , 2000, European Journal of Nuclear Medicine.
[4] David J. Schlyer,et al. Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] F. Vaccarino,et al. Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities. , 1996, Journal of psychiatry & neuroscience : JPN.
[7] J. Palacios,et al. Autoradiography of antidepressant binding sites in the human brain: localization using [3h]imipramine and [3h]paroxetine , 1988, Neuroscience.
[8] L. Cohen. Rational Drug Use in the Treatment of Depression , 1997, Pharmacotherapy.
[9] H. Kung,et al. Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [123I]IDAM , 1999, European Journal of Nuclear Medicine.
[10] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[11] T. Brewerton,et al. Eating disorders and depression: Is there a serotonin connection? , 1990, Biological Psychiatry.
[12] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[14] H. Meltzer. Role of Serotonin in Depression a , 1990, Annals of the New York Academy of Sciences.
[15] P. Acton,et al. Selective in vitro and in vivo binding of [125I]ADAM to serotonin transporters in rat brain , 2000, Synapse.
[16] H. Kung,et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] J. Mann,et al. The role of in vivo neurotransmitter system imaging studies in understanding major depression. , 1998, Biological psychiatry.
[18] Mann Jj. The role of in vivo neurotransmitter system imaging studies in understanding major depression. , 1998 .
[19] Robert B Innis,et al. Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression , 1998, Biological Psychiatry.
[20] P. Acton,et al. Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAM. , 1999, European journal of nuclear medicine.
[21] P. Acton,et al. A novel serotonin transporter ligand: (5-iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol. , 2000, Nuclear medicine and biology.
[22] P. Acton,et al. A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol. , 1999 .
[23] D J Brooks,et al. Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] D. Riche,et al. Anatomical atlas of the baboon's brain in the orbito-meatal plane used in experimental positron emission tomography , 1988, Brain Research Bulletin.
[25] Y. Agid,et al. Distribution of Specific High‐Affinity Binding Sites for [3H]Imipramine in Human Brain , 1981, Journal of neurochemistry.
[26] P. Acton,et al. Single-photon emission tomography imaging of serotonin transporters in the nonhuman primate brain with [123I]ODAM , 1999, European Journal of Nuclear Medicine.
[27] D. Kupfer,et al. Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging , 1998, Neuropsychopharmacology.
[28] P. Acton,et al. Characterization of [123I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters , 1999, European Journal of Nuclear Medicine.
[29] P. Acton,et al. 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand. , 2000, Nuclear medicine and biology.